| Dr Boyd Neil Cole, MD | |
|
1002 E South Temple, #205, Salt Lake City, UT 84102-1525 | |
| (801) 533-0324 | |
| (801) 539-0220 |
| Full Name | Dr Boyd Neil Cole |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 54 Years |
| Location | 1002 E South Temple, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114065893 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 157681-1205 (Utah) | Secondary |
| 208200000X | Plastic Surgery | 157681-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intermountain Medical Center | Murray, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
IRIN examines the results of a report by the aid watchdog group Publish What You Fund that examines "whether donors publish information about their budgets, their allocation and procurement policies, or audit reports on their own performance" and "finds that most international aid donors are still not open enough about their aid programs, and some offer no information at all."
A new study by University of Minnesota biomedical engineers shows how they stopped cancer cells from moving and spreading, even when the cells changed their movements. The discovery could have a major impact on millions of people undergoing therapies to prevent the spread of cancer within the body.
"These provisions mean increased access for the patients of today and renewed hope for the patients of tomorrow. In addition, they will help create high-wage, high-value jobs in our nation's burgeoning biotech sector and help maintain U.S. global leadership in innovation."
A case study published in the current issue of the American Journal of Health-System Pharmacists, demonstrates the positive impact of a diabetes management program designed to educate and motivate members to engage in their health care. The program was implemented by CVS Caremark and Polk County, Florida, a self-insured government employer client.
Genentech, a member of the Roche Group, announced today that a second large, Phase III, international study showed that the combination of Avastin® (bevacizumab) and chemotherapy, followed by the continued use of Avastin alone, increased the time women with previously untreated ovarian cancer lived without the disease worsening (progression-free survival or PFS, the primary endpoint), compared to chemotherapy alone.
› Verified 5 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
IRIN examines the results of a report by the aid watchdog group Publish What You Fund that examines "whether donors publish information about their budgets, their allocation and procurement policies, or audit reports on their own performance" and "finds that most international aid donors are still not open enough about their aid programs, and some offer no information at all."
A new study by University of Minnesota biomedical engineers shows how they stopped cancer cells from moving and spreading, even when the cells changed their movements. The discovery could have a major impact on millions of people undergoing therapies to prevent the spread of cancer within the body.
"These provisions mean increased access for the patients of today and renewed hope for the patients of tomorrow. In addition, they will help create high-wage, high-value jobs in our nation's burgeoning biotech sector and help maintain U.S. global leadership in innovation."
A case study published in the current issue of the American Journal of Health-System Pharmacists, demonstrates the positive impact of a diabetes management program designed to educate and motivate members to engage in their health care. The program was implemented by CVS Caremark and Polk County, Florida, a self-insured government employer client.
Genentech, a member of the Roche Group, announced today that a second large, Phase III, international study showed that the combination of Avastin® (bevacizumab) and chemotherapy, followed by the continued use of Avastin alone, increased the time women with previously untreated ovarian cancer lived without the disease worsening (progression-free survival or PFS, the primary endpoint), compared to chemotherapy alone.
› Verified 5 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
IRIN examines the results of a report by the aid watchdog group Publish What You Fund that examines "whether donors publish information about their budgets, their allocation and procurement policies, or audit reports on their own performance" and "finds that most international aid donors are still not open enough about their aid programs, and some offer no information at all."
A new study by University of Minnesota biomedical engineers shows how they stopped cancer cells from moving and spreading, even when the cells changed their movements. The discovery could have a major impact on millions of people undergoing therapies to prevent the spread of cancer within the body.
"These provisions mean increased access for the patients of today and renewed hope for the patients of tomorrow. In addition, they will help create high-wage, high-value jobs in our nation's burgeoning biotech sector and help maintain U.S. global leadership in innovation."
A case study published in the current issue of the American Journal of Health-System Pharmacists, demonstrates the positive impact of a diabetes management program designed to educate and motivate members to engage in their health care. The program was implemented by CVS Caremark and Polk County, Florida, a self-insured government employer client.
Genentech, a member of the Roche Group, announced today that a second large, Phase III, international study showed that the combination of Avastin® (bevacizumab) and chemotherapy, followed by the continued use of Avastin alone, increased the time women with previously untreated ovarian cancer lived without the disease worsening (progression-free survival or PFS, the primary endpoint), compared to chemotherapy alone.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Boyd Neil Cole, MD 1002 E South Temple, #205, Salt Lake City, UT 84102-1525 Ph: (801) 533-0324 | Dr Boyd Neil Cole, MD 1002 E South Temple, #205, Salt Lake City, UT 84102-1525 Ph: (801) 533-0324 |
News Archive
IRIN examines the results of a report by the aid watchdog group Publish What You Fund that examines "whether donors publish information about their budgets, their allocation and procurement policies, or audit reports on their own performance" and "finds that most international aid donors are still not open enough about their aid programs, and some offer no information at all."
A new study by University of Minnesota biomedical engineers shows how they stopped cancer cells from moving and spreading, even when the cells changed their movements. The discovery could have a major impact on millions of people undergoing therapies to prevent the spread of cancer within the body.
"These provisions mean increased access for the patients of today and renewed hope for the patients of tomorrow. In addition, they will help create high-wage, high-value jobs in our nation's burgeoning biotech sector and help maintain U.S. global leadership in innovation."
A case study published in the current issue of the American Journal of Health-System Pharmacists, demonstrates the positive impact of a diabetes management program designed to educate and motivate members to engage in their health care. The program was implemented by CVS Caremark and Polk County, Florida, a self-insured government employer client.
Genentech, a member of the Roche Group, announced today that a second large, Phase III, international study showed that the combination of Avastin® (bevacizumab) and chemotherapy, followed by the continued use of Avastin alone, increased the time women with previously untreated ovarian cancer lived without the disease worsening (progression-free survival or PFS, the primary endpoint), compared to chemotherapy alone.
› Verified 5 days ago
Dr. Grant Andreas Fairbanks, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1151 East 3900 South, Suite #b110, Salt Lake City, UT 84124 Phone: 801-268-8838 Fax: 801-268-8264 | |
Brittany M. Foley, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 30 N Mario Capecchi Dr Rm, Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Dr. Jason Dayne Petersen, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5353 S 960 E, #150, Salt Lake City, UT 84117 Phone: 801-261-5791 Fax: 801-747-7740 | |
Dr. David Snow Thomas, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 370 9th Ave, 200, Salt Lake City, UT 84103 Phone: 801-355-0731 Fax: 801-322-1099 | |
Paul Winograd, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 30 N Mario Capecchi Dr Rm 4s100, 5th Floor, Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Dr. Cori Ann Agarwal, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: Division Of Plastic Surgery Administrative Office, 30 North 1900 East 3b205, Salt Lake City, UT 84132 Phone: 801-585-6839 Fax: 801-581-5794 | |
Robert Marcus Teixeira, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 30 N 1900 E # 3b400, Salt Lake City, UT 84132 Phone: 801-581-7719 Fax: 801-581-5794 |